This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Takuya Okada: Innovator in KCNQ2-5 Channel Activators
Introduction
Takuya Okada is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target KCNQ2-5 channels. His innovative work has the potential to address various medical conditions.
Latest Patents
Takuya Okada holds 1 patent for a KCNQ2-5 channel activator. The patent describes a novel compound that exhibits a strong opening action with respect to KCNQ2-5 channels. This compound is represented by a general formula and is intended for use as a prophylactic and therapeutic agent for diseases related to KCNQ2-5 channels, such as dysuria and overactive bladder.
Career Highlights
Takuya Okada is associated with Ono Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in his field. His work has garnered attention for its potential impact on therapeutic strategies for channel-related diseases.
Collaborations
Takuya Okada collaborates with notable colleagues, including Kentaro Yashiro and Masashi Kato. Their combined expertise contributes to the innovative research environment at Ono Pharmaceutical Co., Ltd.
Conclusion
Takuya Okada's contributions to the field of KCNQ2-5 channel activators highlight his role as a key inventor in pharmaceutical innovation. His work promises to enhance treatment options for patients suffering from related medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile